[{"id":"d65895fd-5e96-44d2-9eaf-ccccd79a98f8","acronym":"CAM-VHH1","url":"https://clinicaltrials.gov/study/NCT02683083","created_at":"2021-01-18T13:05:01.093Z","updated_at":"2024-07-02T16:36:57.210Z","phase":"Phase 1","brief_title":"Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients","source_id_and_acronym":"NCT02683083 - CAM-VHH1","lead_sponsor":"Precirix","biomarkers":" HER-2","pipe":"","alterations":" ","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CAM-H2"],"overall_status":"Completed","enrollment":" Enrollment 9","initiation":"Initiation: 10/01/2016","start_date":" 10/01/2016","primary_txt":" Primary completion: 02/05/2018","primary_completion_date":" 02/05/2018","study_txt":" Completion: 02/05/2018","study_completion_date":" 02/05/2018","last_update_posted":"2019-08-07"}]